Anti-enterovirus activity and structure–activity relationship of a series of 2,6-dihalophenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles
- 16 February 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 353 (3), 628-632
- https://doi.org/10.1016/j.bbrc.2006.12.063
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Current Status of Anti-Picornavirus TherapiesCurrent Pharmaceutical Design, 2006
- Phase II, Randomized, Double-Blind, Placebo-Controlled Studies of Ruprintrivir Nasal Spray 2-Percent Suspension for Prevention and Treatment of Experimentally Induced Rhinovirus Colds in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2003
- Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled TrialsClinical Infectious Diseases, 2003
- Pleconaril, a Novel Antipicornaviral AgentPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- FDA panel rejects common cold treatmentThe Lancet Infectious Diseases, 2002
- Treatment of picornavirus infectionsAntiviral Research, 2001
- Treatment of Potentially Life-Threatening Enterovirus Infections with PleconarilClinical Infectious Diseases, 2001
- In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C ProteaseAntimicrobial Agents and Chemotherapy, 1999
- The pentamer channel stiffening model for drug action on human rhinovirus HRV-1AProceedings of the National Academy of Sciences of the United States of America, 1997
- Inhibition of uncoating of poliovirus by arildone, a new antiviral drugVirology, 1979